- Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729679/ )
- Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension - ( https://pubmed.ncbi.nlm.nih.gov/16635049/ )
- Nebivolol - (https://medlineplus.gov/druginfo/meds/a608029.html )
- Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol - ( https://pubmed.ncbi.nlm.nih.gov/18758699/ )
- Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917815/ )
Nebivolol (Zenebi (2.5mg)) is a beta-blocker, prescribed for hypertension either alone or combined with other medications. It is also used for some cases of heart failure. It decreases the amount of blood pumped out from heart. This helps to decrease blood pressure and reduces the workload on the heart.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Zenebi (2.5mg) - Fdc Ltd.
Zenebi (2.5mg) Tablet
Generic : Nebivolol
Substitute/Alternative Medication to Zenebi (2.5mg)
When is Zenebi (2.5mg) prescribed?
It is prescribed for -